Advanced Solid Tumors or Lymphomas
| Status: | Archived |
|---|---|
| Conditions: | Cancer, Lymphoma |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | March 2011 |
A Phase I Trial of ABI-011 Administered Weekly in Patients With Advanced Solid Tumors or Lymphomas
The purpose of this study is to determine the MTD and/or RP2D of ABI-011 when administered
by IV on Day 1, Day 8 and Day 15 with one week of rest for patients with advanced solid
tumor malignancies and lymphomas.
Dose limiting toxicities (DLT), maximum tolerated dose (MTD)
We found this trial at
2
sites
Click here to add this to my saved trials
4201 St Antoine St
Detroit, Michigan 48201
Detroit, Michigan 48201
(313) 577-1429
Wayne State University/Detroit Medical Center Founded in 1868, the Wayne State University School of Medicine...
Click here to add this to my saved trials